IPOs This Week: A Single Offering on Tap After 8 IPOs Last Week

July 2, 2017 by Paul Ausick

The last week of the second quarter was a busy one with eight companies entering the public markets following successful initial public offerings (IPOs). The shortened holiday week ahead has just one IPO on the calendar — a do-over after the company did not complete its IPO last week.

Here’s a rundown of last week’s offerings:

Avenue Therapeutics Inc. (NASDAQ: ATXI) raised $33 million by raising its offering to 5.5 million and pricing the shares at $6. The company got a 31% first-day pop and closed the week up nearly 38%.

Dova Pharmaceuticals Inc. (NASDAQ: DOVA) raised $75 million in an upsized offering of 4.4 million shares priced at $17, the high end of the expected range. Shares posted a gain of 16.5% at Friday’s close.

Esquire Financial Holdings Inc. (NASDAQ: ESQ) raised $33 million, selling 2.4 million shares at $14, the low end of the expected range. The first-day pop of nearly 9% didn’t last, however, and the stock ended the week up 6.1%.

Blue Apron Holdings Inc. (NYSE: APRN) sold 30 million shares at $15, the low end of the expected range, and raised $300 million. Shares traded flat on the first day of trading and ended the week down 6.6%.

Byline Bancorp Inc. (NYSE: BY) sold 5.7 million shares at $19, the low end of its expected range, raising $108 million. A first-day, Friday pop of .5.5% is where the stock ended the week.

Tintri Inc. (NASDAQ: TNTR) sold 8.6 million shares in a downsized offering at $7 a share, the low end of the expected range. The company raised $60 and got a first-day pop of 3.9% after is Friday IPO.

Mersana Therapeutics Inc. (NASDAQ: MRSN) sold 5 million shares at $15, the midpoint of the expected range, raising $75 million. Shares broke issue to close down 6.7% and closed the week down 6.9%.

Aileron Therapeutics Inc. (NASDAQ: ALRN) sold 3.8 million shares at $15, the low end of the expected range, to raise $56 million. Shares broke issue on the first day of trading, down 28% and closed the week down nearly 26%.

Through the week ending June 30 IPO ETF manager Renaissance Capital reported that 77 IPOs have priced in the U.S. so far this year, up about 83% year over year. Total proceeds raised through last week equaled $20.5 billion, up 230% year over year. For 2016, Renaissance Capital reported a total of 105 IPOs, down 38% year over year from 170 in 2015. Total 2016 proceeds amounted to $18.8 billion compared with a 2015 total of $30 billion. Renaissance Capital does not include “best efforts” or blank-check companies in its totals, nor does it include IPOs that raise less than $10 million.

The week’s lone scheduled IPO Akcea Therapeutics Inc., a late-stage biopharmaceutical company commercializing treatments for patients with serious cardiometabolic diseases caused by lipid disorders. The company plans to offer 9.6 million shares in an expected price range of $12 to $14 to raise $125 million at an implied market cap of $658 million. Underwriters are Cowen & Co., Stifel, Wells Fargo Securities, and BMO Capital Markets. Shares are listed as day-to-day and will be listed on the Nasdaq under the ticker symbol AKCA.

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.